We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

LeMaitre Vascular Inc (LMAT) NPV

Sell:$65.11 Buy:$66.16 Change: $2.90 (4.60%)
NASDAQ:1.77%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$65.11
Buy:$66.16
Change: $2.90 (4.60%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$65.11
Buy:$66.16
Change: $2.90 (4.60%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

Contact details

Address:
63 2nd Ave
BURLINGTON
01803-4413
United States
Telephone:
+1 (781) 2212266
Website:
https://www.lemaitre.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LMAT
ISIN:
US5255582018
Market cap:
$1.44 billion
Shares in issue:
22.45 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • George LeMaitre
    Chairman of the Board, Chief Executive Officer
  • David Roberts
    President, Director
  • Joseph Pellegrino
    Chief Financial Officer, Director
  • Ryan Connelly
    Senior Vice President - Advanced Manufacturing Engineering
  • Andrew Hodgkinson
    Senior Vice President - Clinical, Regulatory, Quality Affairs
  • Trent Kamke
    Senior Vice President - Operations
  • Stephane Maier
    Senior Vice President, EMEA Operations
  • Giovannella Deiure
    Vice President - Sales, Southern Europe
  • Helen Goulding
    Vice President - Sales, Northern Europe
  • Chance Kriesel
    Vice President - Sales, The Americas

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.